This Recombinant Human Tumor necrosis factor ligand superfamily member 13B (TNFSF13B), partial, Biotinylated (Active) spans the amino acid sequence from region 134-285aa. Purity: Greater than 92% as determined by SDS-PAGE.
Biological Origin: Homo sapiens (Human). Biological Activity: Measured by its binding ability in a functional ELISA. Immobilized human BCMA at 5 µg/ml can bind Biotinylated human TNFSF13B, the EC50 is 0.1752-0.3657 ng/ml. Measured by its binding ability in a functional ELISA. Immobilized human TNFRSF13C at 2 µg/ml can bind Biotinylated human TNFSF13B, the EC50 is 0.2699-0.5613 ng/ml. Application Notes: We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Please reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL.We recommend to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final concentration of glycerol is 50%. Customers could use it as reference
orb1095885
(Tris-Glycine gel) Discontinuous SDS-PAGE (reduced) with 5% enrichment gel and 15% separation gel.
orb1095885
Measured by its binding ability in a functional ELISA. Immobilized human BCMA at 5 µg/ml can bind Biotinylated human TNFSF13B, the EC50 is 0.1752-0.3657 ng/ml.
(Tris-Glycine gel) Discontinuous SDS-PAGE (reduced) with 5% enrichment gel and 15% separation gel.
Measured by its binding ability in a functional ELISA. Immobilized human TNFRSF13C at 2 µg/ml can bind Biotinylated human TNFSF13B, the EC50 is 0.2699-0.5613 ng/ml.
The purity of TNFSF13B was greater than 90% as determined by SEC-HPLC.
* VAT and and shipping costs not included. Errors and price changes excepted
